201 related articles for article (PubMed ID: 31135089)
1. Serum TWEAK in acne vulgaris: An unknown soldier.
El-Taweel AEI; Salem RM; Abdelrahman AMN; Mohamed BAE
J Cosmet Dermatol; 2020 Feb; 19(2):514-518. PubMed ID: 31135089
[TBL] [Abstract][Full Text] [Related]
2. Correlation between the severity and type of acne lesions with serum zinc levels in patients with acne vulgaris.
Rostami Mogaddam M; Safavi Ardabili N; Maleki N; Soflaee M
Biomed Res Int; 2014; 2014():474108. PubMed ID: 25157359
[TBL] [Abstract][Full Text] [Related]
3. Serum irisin: A prognostic marker for severe acne vulgaris.
Mustafa AI; El-Shimi OS
J Cosmet Dermatol; 2018 Oct; 17(5):931-934. PubMed ID: 30238599
[TBL] [Abstract][Full Text] [Related]
4. Serum and salivary adipsin levels and its association with insulin resistance in acne vulgaris patients.
Albalwa K; Kenawy M; El-Fallah AA; Salem RM
J Cosmet Dermatol; 2023 Apr; 22(4):1354-1360. PubMed ID: 36459421
[TBL] [Abstract][Full Text] [Related]
5. Association of brain-derived neurotrophic factor levels and depressive symptoms in young adults with acne vulgaris.
He HY; Tian JL; Deng YQ; Xiong X; Xu Y; Liao YM; Fang J; Feng X; Ye X; Li CQ
BMC Psychiatry; 2019 Jun; 19(1):193. PubMed ID: 31234814
[TBL] [Abstract][Full Text] [Related]
6. HMGB1-RAGE-moesin axis may be indicted for acne vulgaris.
Salem RM; El-Fallah AA; Shaker R
J Cosmet Dermatol; 2022 Apr; 21(4):1642-1646. PubMed ID: 34053168
[TBL] [Abstract][Full Text] [Related]
7. Plasma dermcidin levels in acne patients, and the effect of isotretinoin treatment on dermcidin levels.
Alatas ET; Kara Polat A; Kalayci M; Dogan G; Akin Belli A
Dermatol Ther; 2019 Sep; 32(5):e13044. PubMed ID: 31364786
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D levels in acne vulgaris patients treated with oral isotretinoin.
El-Hamd MA; El Taieb MA; Ibrahim HM; Aly SS
J Cosmet Dermatol; 2019 Feb; 18(1):16-20. PubMed ID: 29460332
[TBL] [Abstract][Full Text] [Related]
9. Serum homocysteine levels in acne patients.
Jiang H; Li C; Wei B; Wang Q; Zhong J; Lu J
J Cosmet Dermatol; 2018 Jun; 17(3):523-526. PubMed ID: 29159884
[TBL] [Abstract][Full Text] [Related]
10. Elevated serum tumour necrosis factor-like weak inducer of apoptosis in alopecia areata: a possible marker of disease severity.
Sayed K; Mohammed F; Abdel Hay R; Ezzeldin N; Rashed L; Fahim A
Clin Exp Dermatol; 2020 Jun; 45(4):426-431. PubMed ID: 31587331
[TBL] [Abstract][Full Text] [Related]
11. In severe acne vulgaris, TNF-α gene variants are connected to increased TNF-α gene expression and insulin resistance.
AbdElneam AI; Alhajlah S; Al-Dhubaibi MS; Bahaj SS; Mohammed GF; Alantry AK; Atef LM
Skin Res Technol; 2024 Jul; 30(7):e13811. PubMed ID: 38923681
[TBL] [Abstract][Full Text] [Related]
12. Changes in serum TNF-like weak inducer of apoptosis (TWEAK) levels and Psoriasis Area Severity Index (PASI) scores in plaque psoriasis patients treated with conventional versus anti-TNF treatments.
Engin B; Tanakol A; Bulut H; Songür A; Vehid HE; Gökalp E; Kutlubay Z; Özkoca D; Tüzün Y; Serdaroğlu S
Int J Dermatol; 2020 Feb; 59(2):207-215. PubMed ID: 31531981
[TBL] [Abstract][Full Text] [Related]
13. Biochemical markers of oxidative and nitrosative stress in acne vulgaris: correlation with disease activity.
Al-Shobaili HA; Alzolibani AA; Al Robaee AA; Meki AR; Rasheed Z
J Clin Lab Anal; 2013 Jan; 27(1):45-52. PubMed ID: 23325743
[TBL] [Abstract][Full Text] [Related]
14. Serum interleukin-17 as a novel biomarker in patients with acne vulgaris.
Ebrahim AA; Mustafa AI; El-Abd AM
J Cosmet Dermatol; 2019 Dec; 18(6):1975-1979. PubMed ID: 30964235
[TBL] [Abstract][Full Text] [Related]
15. Changes in serum desnutrin levels in patients with acne vulgaris.
Demir B; Ucak H; Cicek D; Aydin S; Erden I; Dertlioglu SB
Eur J Dermatol; 2014; 24(5):589-93. PubMed ID: 25152512
[TBL] [Abstract][Full Text] [Related]
16. Involvement of the cytokine TWEAK in the pathogenesis of psoriasis vulgaris, pustular psoriasis, and erythrodermic psoriasis.
Wang H; Wang S; Li L; Wang X; Liu C; Lu M; Xia Y; Liu Y
Cytokine; 2021 Feb; 138():155391. PubMed ID: 33302223
[TBL] [Abstract][Full Text] [Related]
17. [Expression of TWEAK and Its Receptor CD163 in Peripheral Blood of Psoriasis Vulgaris (PV)].
Yang BC; Li MM; Deng XQ; Cao NN; Guo ZP
Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 Sep; 49(5):720-724. PubMed ID: 30378333
[TBL] [Abstract][Full Text] [Related]
18. Lesional and circulating levels of interleukin-17 and 25-hydroxycholecalciferol in active acne vulgaris: Correlation to disease severity.
Abd-Elmaged WM; Nada EA; Hassan MH; Elsadek BEM; Abdelrahim EA; Ahmed NS; Toghan R; Ahmed HTI
J Cosmet Dermatol; 2019 Apr; 18(2):671-676. PubMed ID: 30070012
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of 25-hydroxy vitamin D levels and disease severity in patients with acne vulgaris.
Kemeriz F; Tuncer SÇ; Acar EM; Tuğrul B
Dermatol Ther; 2020 May; 33(3):e13393. PubMed ID: 32268447
[TBL] [Abstract][Full Text] [Related]
20. Serum YKL40: A novel potential link between inflammation and dyslipidemia in acne vulgaris.
Ebrahim A; Mustafa AI; El-Shimi OS; Fathy MA
J Cosmet Dermatol; 2020 May; 19(5):1219-1223. PubMed ID: 31490625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
